预测药师与 HIV 预防用暴露前预防措施（PrEP）相关的发药实践和舒适度。
Predicting Pharmacist Dispensing Practices and Comfort Related to Pre-exposure Prophylaxis for HIV Prevention (PrEP).
机构信息
Indiana University School of Public Health-Bloomington, 1025 E. 7th street, Bloomington, IN, 47405, USA.
Rural Center for AIDS/STD Prevention, Indiana University, Bloomington, IN, USA.
出版信息
AIDS Behav. 2019 Jul;23(7):1925-1938. doi: 10.1007/s10461-018-02383-7.
Abstract
To identify factors associated with pharmacist dispensing practice and comfort counseling patients about pre-exposure prophylaxis for HIV prevention (PrEP). Cross-sectional 2016 census of Indiana managing pharmacists measured PrEP awareness, comfort dispensing and counseling patients. Modified Poisson models with robust error variance estimated relative risks and confidence intervals. 15.8% of 284 pharmacists had dispensed PrEP and 11.6% had consulted about it. Dispensing and comfort counseling were associated with confidence in knowledge about PrEP medication adherence and adverse effects of PrEP medication; awareness about PrEP before the survey, number of full time pharmacists in their pharmacy, and increases in new HIV cases from 2015 to 2016 in communities served. Comfort counseling about PrEP was associated with the belief that pharmacists can be an important resource for HIV and HCV treatment.
摘要
为了确定与药剂师配药实践和为 HIV 预防（PrEP）患者提供舒适咨询相关的因素。2016 年对印第安纳州管理药剂师进行的横断面普查衡量了 PrEP 的知晓率、配药和咨询患者的舒适度。使用稳健方差的修正泊松模型估计了相对风险和置信区间。284 名药剂师中有 15.8%的人配过 PrEP，11.6%的人咨询过 PrEP。配药和咨询舒适度与对 PrEP 药物依从性和 PrEP 药物不良反应知识的信心相关；对 PrEP 的认识，其药店的全职药剂师人数，以及服务社区 2015 年至 2016 年新 HIV 病例的增加。对 PrEP 的舒适咨询与相信药剂师可以成为 HIV 和 HCV 治疗的重要资源有关。
相似文献
1
Predicting Pharmacist Dispensing Practices and Comfort Related to Pre-exposure Prophylaxis for HIV Prevention (PrEP).预测药师与 HIV 预防用暴露前预防措施（PrEP）相关的发药实践和舒适度。
AIDS Behav. 2019 Jul;23(7):1925-1938. doi: 10.1007/s10461-018-02383-7.
2
Exploratory survey of Florida pharmacists' experience, knowledge, and perception of HIV pre-exposure prophylaxis.佛罗里达药剂师对HIV暴露前预防的经验、知识及认知的探索性调查
J Am Pharm Assoc (2003). 2014 Nov-Dec;54(6):610-7. doi: 10.1331/JAPhA.2014.14014.
3
HIV pre-exposure prophylaxis: Exploring the potential for expanding the role of pharmacists in public health.HIV 暴露前预防：探索扩大药剂师在公共卫生中作用的潜力。
J Am Pharm Assoc (2003). 2018 Jul-Aug;58(4):412-420.e3. doi: 10.1016/j.japh.2018.04.007. Epub 2018 May 19.
4
The Pharmacist's Expanding Role in HIV Pre-Exposure Prophylaxis.药剂师在 HIV 暴露前预防中的作用不断扩大。
AIDS Patient Care STDS. 2019 May;33(5):207-213. doi: 10.1089/apc.2018.0294.
5
Understanding community pharmacist perceptions and knowledge about HIV preexposure prophylaxis (PrEP) therapy in a Mountain West state.了解美国西部山区一个州的社区药剂师对艾滋病病毒暴露前预防（PrEP）疗法的看法和知识。
J Am Pharm Assoc (2003). 2016 Sep-Oct;56(5):527-532.e1. doi: 10.1016/j.japh.2016.05.004.
6
Patient perspectives of pharmacists prescribing HIV pre-exposure prophylaxis: A survey of patients receiving antiretroviral therapy.患者对药剂师开具 HIV 暴露前预防药物的看法：接受抗逆转录病毒治疗的患者调查。
J Am Pharm Assoc (2003). 2021 Mar-Apr;61(2):e75-e79. doi: 10.1016/j.japh.2020.09.020. Epub 2020 Oct 14.
7
Awareness, knowledge, and attitudes towards human immunodeficiency virus (HIV) pre-exposure prophylaxis (PrEP) among pharmacy students.药学专业学生对人类免疫缺陷病毒（HIV）暴露前预防（PrEP）的认知、知识及态度
Curr Pharm Teach Learn. 2019 Apr;11(4):352-360. doi: 10.1016/j.cptl.2019.01.011. Epub 2019 Feb 23.
8
HIV pre-exposure prophylaxis awareness, practices, and comfort among urban and rural family medicine physicians.城市和农村家庭医学医师对 HIV 暴露前预防的认知、实践和舒适度。
J Rural Health. 2023 Mar;39(2):469-476. doi: 10.1111/jrh.12723. Epub 2022 Nov 7.
9
Pharmacists as providers of HIV pre-exposure prophylaxis.药剂师作为 HIV 暴露前预防的提供者。
Int J Clin Pharm. 2012 Dec;34(6):803-6. doi: 10.1007/s11096-012-9709-0. Epub 2012 Oct 17.
10
Midwest pharmacists' familiarity, experience, and willingness to provide pre-exposure prophylaxis (PrEP) for HIV.中西部药剂师对 HIV 暴露前预防（PrEP）的了解、经验和提供意愿。
PLoS One. 2018 Nov 14;13(11):e0207372. doi: 10.1371/journal.pone.0207372. eCollection 2018.
引用本文的文献
1
Development and evaluation of an online HIV pre-exposure prophylaxis (PrEP) training program for community pharmacists to implement pharmacy-led PrEP services in Malaysia.为马来西亚社区药剂师开发并评估一项在线艾滋病毒暴露前预防（PrEP）培训计划，以实施由药房主导的PrEP服务。
PLoS One. 2025 Aug 18;20(8):e0328713. doi: 10.1371/journal.pone.0328713. eCollection 2025.
2
A Mixed Methods Evaluation of Pharmacists' Readiness to Provide Long-Acting Injectable HIV Pre-exposure Prophylaxis in California.一项关于加利福尼亚州药剂师准备提供长效注射型 HIV 暴露前预防的混合方法评估。
J Acquir Immune Defic Syndr. 2024 Oct 1;97(2):142-149. doi: 10.1097/QAI.0000000000003470.
3
Facilitators and barriers to community pharmacy PrEP delivery: a scoping review.促进和阻碍社区药房提供 PrEP 的因素：范围综述。
J Int AIDS Soc. 2024 Mar;27(3):e26232. doi: 10.1002/jia2.26232.
4
Come back when you're infected: pharmacy access to sterile syringes in an Arizona Secret Shopper Study, 2023.2023 年亚利桑那州秘密购物者研究：当您感染时再来：药房获得无菌注射器的机会。
Harm Reduct J. 2024 Feb 22;21(1):49. doi: 10.1186/s12954-024-00943-w.
5
The PharmNet Harm Reduction Intervention for Community Pharmacies: Protocol for a Pilot Randomized Controlled Trial.社区药房的PharmNet减少伤害干预措施：一项试点随机对照试验方案
JMIR Res Protoc. 2022 Oct 24;11(10):e42373. doi: 10.2196/42373.
6
Assessing the use of an infographic on pre-exposure prophylaxis for Wisconsin community pharmacists.评估信息图在威斯康星州社区药剂师中的暴露前预防应用。
J Am Pharm Assoc (2003). 2022 Nov-Dec;62(6):1897-1903.e4. doi: 10.1016/j.japh.2022.07.010. Epub 2022 Jul 31.
7
Pharmacy-Based Interventions to Increase Use of HIV Pre-exposure Prophylaxis in the United States: A Scoping Review.基于药学的干预措施在美国提高 HIV 暴露前预防用药的使用率：范围综述。
AIDS Behav. 2022 May;26(5):1377-1392. doi: 10.1007/s10461-021-03494-4. Epub 2021 Oct 20.
8
Cabenuva®: Differentiated service delivery and the community Pharmacists' roles in achieving UNAIDS 2030 target in Nigeria.卡贝努瓦（Cabenuva®）：差异化服务提供以及社区药剂师在尼日利亚实现2030年联合国艾滋病规划署目标中的作用。
Saudi Pharm J. 2021 Aug;29(8):815-819. doi: 10.1016/j.jsps.2021.06.003. Epub 2021 Jun 15.
9
Attitudes about community pharmacy access to HIV prevention medications in California.加利福尼亚州社区药房获取艾滋病毒预防药物的态度。
J Am Pharm Assoc (2003). 2020 Nov-Dec;60(6):e179-e183. doi: 10.1016/j.japh.2020.06.005. Epub 2020 Jul 12.
10
A Narrative Review of Continuing Professional Development Needs for Pharmacists with Respect to Pre-exposure Prophylaxis (PrEP) for Human Immunodeficiency Virus (HIV).关于药剂师在人类免疫缺陷病毒（HIV）暴露前预防（PrEP）方面持续专业发展需求的叙述性综述。
Pharmacy (Basel). 2020 May 11;8(2):84. doi: 10.3390/pharmacy8020084.
本文引用的文献
1
Development of a 10-Item Tool to Identify Advanced Practice Nurse Readiness to Prescribe Pre-exposure Prophylaxis.开发一种 10 项工具，以确定高级执业护士准备开具暴露前预防用药的情况。
J Assoc Nurses AIDS Care. 2019 May-Jun;30(3):312-320. doi: 10.1097/JNC.0000000000000038.
2
The prevalence of pre-exposure prophylaxis use and the pre-exposure prophylaxis-to-need ratio in the fourth quarter of 2017, United States.2017 年第四季度美国暴露前预防用药的使用情况和暴露前预防用药的需求比。
Ann Epidemiol. 2018 Dec;28(12):841-849. doi: 10.1016/j.annepidem.2018.06.005. Epub 2018 Jun 15.
3
Predicting pharmacy naloxone stocking and dispensing following a statewide standing order, Indiana 2016.预测在全州范围内的常备医嘱后，药房纳洛酮的库存和配药情况，印第安纳州，2016 年。
Drug Alcohol Depend. 2018 Jul 1;188:187-192. doi: 10.1016/j.drugalcdep.2018.03.032. Epub 2018 Apr 26.
4
Predicting pharmacy syringe sales to people who inject drugs: Policy, practice and perceptions.预测注射吸毒者的药店注射器销售：政策、实践和看法。
Int J Drug Policy. 2018 Jun;56:46-53. doi: 10.1016/j.drugpo.2018.02.024. Epub 2018 Mar 17.
5
Hospital and Community Pharmacists' Perceptions of Which Competences Are Important for Their Practice.医院和社区药剂师对哪些能力对其职业实践至关重要的看法。
Pharmacy (Basel). 2016 Jun 15;4(2):21. doi: 10.3390/pharmacy4020021.
6
Awareness, Willingness, and Use of Pre-exposure Prophylaxis Among Men Who Have Sex With Men in Washington, DC and Miami-Dade County, FL: National HIV Behavioral Surveillance, 2011 and 2014.华盛顿特区和佛罗里达州迈阿密-戴德县男男性行为者对暴露前预防的知晓度、意愿及使用情况：2011年和2014年全国艾滋病毒行为监测
J Acquir Immune Defic Syndr. 2017 Jul 1;75 Suppl 3(Suppl 3):S375-S382. doi: 10.1097/QAI.0000000000001414.
7
Awareness and attitudes of pre-exposure prophylaxis for HIV prevention among physicians in Guatemala: Implications for country-wide implementation.危地马拉医生对预防艾滋病病毒暴露前预防的认知与态度：对全国实施的启示
PLoS One. 2017 Mar 3;12(3):e0173057. doi: 10.1371/journal.pone.0173057. eCollection 2017.
8
PrEP Awareness, Familiarity, Comfort, and Prescribing Experience among US Primary Care Providers and HIV Specialists.美国初级保健提供者和HIV专家对暴露前预防（PrEP）的认知、熟悉程度、接受度及处方经验
AIDS Behav. 2017 May;21(5):1256-1267. doi: 10.1007/s10461-016-1625-1.
9
Using the hybrid method to survey U.S. pharmacists: Applying lessons learned to leverage technology.运用混合方法对美国药剂师进行调查：借鉴经验以利用技术。
Res Social Adm Pharm. 2017 Jan-Feb;13(1):250-252. doi: 10.1016/j.sapharm.2016.09.007. Epub 2016 Sep 29.
10
Understanding community pharmacist perceptions and knowledge about HIV preexposure prophylaxis (PrEP) therapy in a Mountain West state.了解美国西部山区一个州的社区药剂师对艾滋病病毒暴露前预防（PrEP）疗法的看法和知识。
J Am Pharm Assoc (2003). 2016 Sep-Oct;56(5):527-532.e1. doi: 10.1016/j.japh.2016.05.004.
Zotero 插件